ProQR Therapeutics NV Vs. Pharming Group Industry Stock Comparison

Sell

25

PRQR
ProQR Therapeutics NV

Last Price:

1.72

Seasonality Move:

-1.1%

Sell

42

PHAR
Pharming Group

Last Price:

7.54

Seasonality Move:

-9.32%

Sell

25

ProQR Therapeutics NV (PRQR) is a Sell

Is ProQR Therapeutics NV a Buy, Sell or Hold?

The current ProQR Therapeutics NV [PRQR] share price is $1.73. The Score for PRQR is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
PRQR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

42

Pharming Group (PHAR) is a Sell

Is Pharming Group a Buy, Sell or Hold?

The current Pharming Group [PHAR] share price is $7.59. The Score for PHAR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
PHAR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRQR Stock Price Chart

What is ProQR Therapeutics NV's stock price today?

The ProQR Therapeutics NV share price today is $1.73
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.

PHAR Stock Price Chart

What is Pharming Group's stock price today?

The Pharming Group share price today is $7.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAR is experiencing slight selling pressure.

PRQR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.05	Sell
Relative Strength Index (14 RSI):	30.02	Sell
Chaikin Money Flow:	-51308	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.81 - 2.07)	Sell
Bollinger Bands (100):	(1.74 - 2.02)	Sell

PHAR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.02	Sell
Relative Strength Index (14 RSI):	48.35	Sell
Chaikin Money Flow:	-982	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(7.31 - 7.97)	Sell
Bollinger Bands (100):	(7.57 - 9.15)	Sell

PRQR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.82	Sell
20-day SMA:	1.9	Sell
50-day SMA:	1.92	Sell
200-day SMA:	1.99	Sell
8-day EMA:	1.81	Sell
20-day EMA:	1.87	Sell
50-day EMA:	1.9	Sell
200-day EMA:	1.91	Sell

PHAR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	7.68	Sell
20-day SMA:	7.57	Buy
50-day SMA:	7.88	Sell
200-day SMA:	9.91	Sell
8-day EMA:	7.7	Sell
20-day EMA:	7.65	Sell
50-day EMA:	7.88	Sell
200-day EMA:	9.39	Sell

ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.

Pharming Group Earnings Growth & PHAR Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.

ProQR Therapeutics NV Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pharming Group Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):